2. Signaling Pathways
  3. Others
  4. Amino Acid Derivatives

Amino Acid Derivatives

Amino Acid Derivatives are bioactive molecules formed through chemical modifications or metabolic transformations of amino acids. They are widely present in living organisms and play crucial roles in physiological, psychological, and athletic performance.
The functions of these derivatives primarily include enhancing energy supply, regulating neurotransmitters, promoting fat metabolism, and reducing muscle damage. For example, creatine can increase muscle strength, enhance ATP resynthesis, and improve short-duration high-intensity exercise performance; tyrosine, as a precursor of dopamine and norepinephrine, helps enhance cognitive function and improve mood, particularly in sleep deprivation conditions, exhibiting anti-fatigue effects; carnitine facilitates fatty acid oxidation in the heart and skeletal muscles, improving endurance performance; HMB (β-hydroxy-β-methylbutyrate) reduces muscle breakdown and promotes muscle mass gain; while taurine exhibits antioxidant and antihypertensive properties and reduces oxidative stress induced by exercise.
Metabolic abnormalities or improper supplementation of amino acid derivatives may be associated with various diseases. For instance, tyrosine metabolism disorders can disrupt neurotransmitter balance, potentially leading to depression or stress-related disorders; elevated ADMA (asymmetric dimethylarginine) levels can inhibit nitric oxide synthesis, increasing the risk of cardiovascular diseases; carnitine deficiency is linked to certain genetic muscle disorders, impairing fat metabolism and energy production. Additionally, HMB may help slow muscle loss under specific conditions, while taurine intake is associated with improved cardiovascular health. Although some of the effects of these derivatives remain debated, they hold significant potential applications in sports nutrition, neurological regulation, and metabolic health.

Amino Acid Derivatives Related Products (1580):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W048730
    Fmoc-Phe(4-tBu)-OH
    		99.94%
    Fmoc-Phe(4-tBu)-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize rOicPaPhe(p-Me)-NH(2) with platelet aggregation activation inhibitory activity.
    Fmoc-Phe(4-tBu)-OH
  • HY-W002436
    Fmoc-D-HoPhe-OH
    		99.97%
    Fmoc-D-HoPhe-OH is a phenylalanine derivative.
    Fmoc-D-HoPhe-OH
  • HY-30232
    L-Glutamate-γ-benzyl ester
    		99.88%
    L-Glutamate-γ-benzyl ester is a glutamic acid derivative.
    L-Glutamate-γ-benzyl ester
  • HY-W039947
    N6-[(2E)-1-Oxo-2-buten-1-yl]-L-lysine
    		99.56%
    N6-[(2E)-1-Oxo-2-buten-1-yl]-L-lysine is a lysine derivative.
    N6-[(2E)-1-Oxo-2-buten-1-yl]-L-lysine
  • HY-W548477
    H-Lys(Fmoc)-OH hydrochloride
    		99.15%
    H-Lys(Fmoc)-OH hydrochloride is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize diacylated GLP-1 derivatives with antidiabetic activity.
    H-Lys(Fmoc)-OH hydrochloride
  • HY-W110126
    (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid
    		99.18%
    (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid is a lysine derivative.
    (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid
  • HY-W012966
    3-Amino-2-hydroxypropanoic acid
    		≥98.0%
    3-Amino-2-hydroxypropanoic acid is a serine derivative.
    3-Amino-2-hydroxypropanoic acid
  • HY-W013940
    DL-Cystine
    		≥98.0%
    DL-Cystine is a cysteine derivative.
    DL-Cystine
  • HY-W009328
    Z-Asp-OMe
    		99.75%
    Z-Asp-OMe is an aspartic acid derivative.
    Z-Asp-OMe
  • HY-135170
    Myristoyl-L-carnitine chloride
    		99.92%
    Myristoyl-L-Carnitine Chloride is a natural long-chain glycoline, amino acid derivative.
    Myristoyl-L-carnitine chloride
  • HY-W010162
    H-Ala-Ala-OH
    H-Ala-Ala-OH (L-Alanyl-L-alanine; Ala-Ala) is a nonpolar dipeptide that is absorbed by human intestinal Caco-2 cells. The transport of alanine (Ala), like proton/amino acid symport, can lead to cytoplasmic acidification.
    H-Ala-Ala-OH
  • HY-P10493A
    NY-ESO-1 (157-165) peptide TFA
    NY-ESO-1 (157-165) peptide (TFA) is a peptide fragment from NY-ESO-1 protein. NY-ESO-1 (157-165) peptide (TFA) can activate the immune system, especially for HLA-A2 positive individuals, it can be recognized by CD8+ T cells, thus triggering an immune response. NY-ESO-1 (157-165) peptide (TFA) is expressed in a variety of tumors and can be used as a target for tumor immunotherapy.
    NY-ESO-1 (157-165) peptide TFA
  • HY-W005720
    H-Phg(4-Cl)-OH
    		98.85%
    H-Phg(4-Cl)-OH (L-4-Chlorophenylglycine) is a Glycine (HY-Y0966) derivative.
    H-Phg(4-Cl)-OH
  • HY-W016835
    (2S,3S)-2-Acetamido-3-methylpentanoic acid
    (2S,3S)-2-Acetamido-3-methylpentanoic acid is an isoleucine derivative.
    (2S,3S)-2-Acetamido-3-methylpentanoic acid
  • HY-W068839
    L-Phenylalanyl-L-leucine
    		98.02%
    L-Phenylalanyl-L-leucine is a leucine derivative.
    L-Phenylalanyl-L-leucine
  • HY-103664
    Fmoc-1,6-diaminohexane
    		99.29%
    Fmoc-1,6-diaminohexane is an analog of Osw-1 which has the potential for Alzheimer's disease and cancer treatment from patent US 20140135279 A1.
    Fmoc-1,6-diaminohexane
  • HY-W008958
    Fmoc-MeSer(Bzl)-OH
    		99.80%
    Fmoc-MeSer(Bzl)-OH is a serine derivative.
    Fmoc-MeSer(Bzl)-OH
  • HY-W010825
    Fmoc-Phe(2-Br)-OH
    Fmoc-Phe(2-Br)-OH is a phenylalanine derivative.
    Fmoc-Phe(2-Br)-OH
  • HY-W011280
    (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid
    (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid is a phenylalanine derivative.
    (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid
  • HY-W041866
    Boc-Phe(3-Br)-OH
    		99.85%
    Boc-Phe(3-Br)-OH is a phenylalanine derivative.
    Boc-Phe(3-Br)-OH